- Home
- / BBI Life Sciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BBI Life Sciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$10.3 M
Revenue
¥703.8 M
FY, 2019
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 |
|---|---|---|
| Revenue | 581.6M | 703.8M |
| Cost of goods sold | 240.9M | 288.0M |
| Gross profit | 342.8M | 417.2M |
| Gross profit margin, % | 59.3% | |
| Operating expense total | 226.6M | 275.5M |
| Depreciation and amortization | 29.8M | 41.5M |
| EBITDA | 115.5M | 141.1M |
| EBITDA margin, % | 20.0% | |
| EBIT | 84.1M | 101.5M |
| EBIT margin, % | 14.4% | |
| Interest income | 3.7M | 2.6M |
| Interest expense | 1.0M | 3.2M |
| Pre tax profit | 87.4M | 99.6M |
| Income tax expense | 11.5M | 13.6M |
| Net Income | 75.9M | 86.0M |